Pseudomyxoma peritonei: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 16: Line 16:
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


{{SK}} PMP; jelly belly
{{SK}} PMP; jelly belly
Line 63: Line 65:
[[Category:Surgery]]
[[Category:Surgery]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Needs content]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 15:48, 17 September 2012

Pseudomyxoma peritonei
ICD-10 C48.2
ICD-9 197.6
ICD-O: M8480
DiseasesDB 31498
MeSH D011553

WikiDoc Resources for Pseudomyxoma peritonei

Articles

Most recent articles on Pseudomyxoma peritonei

Most cited articles on Pseudomyxoma peritonei

Review articles on Pseudomyxoma peritonei

Articles on Pseudomyxoma peritonei in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pseudomyxoma peritonei

Images of Pseudomyxoma peritonei

Photos of Pseudomyxoma peritonei

Podcasts & MP3s on Pseudomyxoma peritonei

Videos on Pseudomyxoma peritonei

Evidence Based Medicine

Cochrane Collaboration on Pseudomyxoma peritonei

Bandolier on Pseudomyxoma peritonei

TRIP on Pseudomyxoma peritonei

Clinical Trials

Ongoing Trials on Pseudomyxoma peritonei at Clinical Trials.gov

Trial results on Pseudomyxoma peritonei

Clinical Trials on Pseudomyxoma peritonei at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pseudomyxoma peritonei

NICE Guidance on Pseudomyxoma peritonei

NHS PRODIGY Guidance

FDA on Pseudomyxoma peritonei

CDC on Pseudomyxoma peritonei

Books

Books on Pseudomyxoma peritonei

News

Pseudomyxoma peritonei in the news

Be alerted to news on Pseudomyxoma peritonei

News trends on Pseudomyxoma peritonei

Commentary

Blogs on Pseudomyxoma peritonei

Definitions

Definitions of Pseudomyxoma peritonei

Patient Resources / Community

Patient resources on Pseudomyxoma peritonei

Discussion groups on Pseudomyxoma peritonei

Patient Handouts on Pseudomyxoma peritonei

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei

Healthcare Provider Resources

Symptoms of Pseudomyxoma peritonei

Causes & Risk Factors for Pseudomyxoma peritonei

Diagnostic studies for Pseudomyxoma peritonei

Treatment of Pseudomyxoma peritonei

Continuing Medical Education (CME)

CME Programs on Pseudomyxoma peritonei

International

Pseudomyxoma peritonei en Espanol

Pseudomyxoma peritonei en Francais

Business

Pseudomyxoma peritonei in the Marketplace

Patents on Pseudomyxoma peritonei

Experimental / Informatics

List of terms related to Pseudomyxoma peritonei

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Synonyms and keywords: PMP; jelly belly

Overview

Pseudomyxoma peritonei is an uncommon tumor known for its production of mucus in the abdominal cavity.[1] The tumor is not harmful by itself, but the mucus has no place to go inside the abdominal cavity. If left untreated, it will eventually build up to the point where it compresses vital structures: the colon, the liver, kidneys, etc.

Unlike most cancers, PMP does not spread through the lymphatic system or through the bloodstream. PMP is most commonly associated with cancer of the appendix; mucinous tumors of the ovary have also been implicated.

Diagnosis

PMP may be diagnosed with a range of conditions. While the majority of PMP cases are associated with appendiceal carcinomas,[2] other conditions may also be found, including disseminated peritoneal adenomucinosis (DPAM), peritoneal carcinomas, several mucinous cancers (mucinous adenocarcinoma, mucinous cystadenoma, and mucinous cystadenocarcinoma), as well as other disease states.[3]

Symptoms

Symptoms may include abdominal or pelvic pain and/or bloating, distension, digestive disorders, weight changes, increased girth and infertility.

PMP is commonly discovered during surgery for other conditions, i.e., hernia repair, following which an experienced pathologist can confirm the diagnosis. Due to the rarity of this disease, it is important to obtain an accurate diagnosis so that appropriate treatment may be obtained. Diagnosis is confirmed through pathology. Diagnostic tests may include CT scans, and the evaluation of tumor markers.

Treatment

Treatment for PMP is variable, both due to its rarity and to its frequently slow-growing nature. Treatment ranges from watchful waiting to debulking and cytoreductive surgery.[4]

Medical Therapy

Chemotherapy is infused directly into the abdominal cavity to kill remaining cancerous cells. The drugs may be manually applied to the cavity for an hour or two as the last step in the surgery, or ports are installed to allow circulation and/or drainage of the chemicals for one to five days after surgery. Cancer cells reproduce quickly on scar tissue, and there is lots of scar tissue after surgery. Even with aggressive, heated chemotherapy treatment PMP recurrence is common and further surgeries are frequently needed. Patients often require frequent CT scans for a period of time to spot any tumor regrowth.

Oral and intravenous chemotherapy has become more commonly used during the past five years. In cases in patients have experienced stability in tumor growth through treatment with various systemic chemotherapies.

Additionally recent (2003) publications linking the MUC2 enzyme overexpression to Pseudomyxoma cell reproduction has launched research efforts into additional drug treatments.

Surgery

Most commonly, treatment for PMP involves surgery performed by specific specialists trained in treating this disease.

When appropriate, surgery may include intraperitoneal hyperthermic chemotherapy, or post operative systemic chemotherapy.

In situations where surgery is not required immediately, patients can be monitored via CT scans, tumor marker laboratory tests, and physical symptoms, to determined when, and if, surgery is warranted.

Although some surgical procedures may be rather extensive, patients can and do recover from surgery, and the majority of these patients can and do live productive lives.

In debulking, the surgeon attempts to remove as much tumor as possible, while cytoreductive surgery involves surgical removal of the peritoneum and any adjacent organs which appear to have tumor seeding. Since the mucus tends to pool at the bottom of the abdominal cavity, it is common to remove the ovaries, fallopian tubes, uterus, and parts of the large intestine. Depending upon the spread of the tumor, other organs might be removed, including but not limited to the gallbladder, spleen, and all or portions of the small intestine and/or stomach. For organs that cannot be removed safely (like the liver), the surgeon strips off the tumor from the surface. [5]

References

  1. Qu Z, Liu L (2006). "Management of pseudomyxoma peritonei". World J Gastroenterol. 12 (38): 6124–7. PMID 17036382.
  2. Young R (2004). "Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms". Semin Diagn Pathol. 21 (2): 134–50. PMID 15807473.
  3. Jacquemin G, Laloux P (2005). "Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases". Acta Chir Belg. 105 (2): 127–33. PMID 15906901.
  4. Sugarbaker P (2006). "New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?". Lancet Oncol. 7 (1): 69–76. PMID 16389186.
  5. Harmon R, Sugarbaker P (2005). "Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer". Int Semin Surg Oncol. 2 (1): 3. PMID 15701175.

Template:Epithelial neoplasms


Template:WikiDoc Sources